Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
3.320
-0.070 (-2.06%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Affimed Revenue
Affimed had revenue of 210.00K EUR in the quarter ending June 30, 2024, a decrease of -90.03%. This brings the company's revenue in the last twelve months to 7.43M, down -78.06% year-over-year. In the year 2023, Affimed had annual revenue of 13.91M, down -67.39%.
Revenue (ttm)
7.43M EUR
Revenue Growth
-78.06%
P/S Ratio
6.42
Revenue / Employee
97,750 EUR
Employees
76
Market Cap
52.06M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.91M | -28.76M | -67.39% |
Dec 31, 2022 | 42.67M | 1.12M | 2.70% |
Dec 31, 2021 | 41.55M | 12.69M | 43.99% |
Dec 31, 2020 | 28.86M | 7.43M | 34.66% |
Dec 31, 2019 | 21.43M | -2.30M | -9.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Atara Biotherapeutics | 62.39M |
Cytosorbents | 37.16M |
Qilian International Holding Group | 29.87M |
SCYNEXIS | 9.67M |
Kronos Bio | 8.41M |
Kezar Life Sciences | 7.00M |
OncoCyte | 1.02M |
Envoy Medical | 302.00K |
AFMD News
- 6 weeks ago - Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewsWire
- 7 weeks ago - Affimed N.V. (AFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Affimed Reports Second Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 7 weeks ago - Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha
- 7 weeks ago - Affimed Appoints Shawn M. Leland as Chief Executive Officer - GlobeNewsWire
- 2 months ago - Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 - GlobeNewsWire
- 4 months ago - Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Affimed Reports First Quarter 2024 Financial Results & Business Update - GlobeNewsWire